Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |